Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconKRYSKrystal Biotech$4.01bn28.11n/a
us flag iconCYTKCytokinetics$3.96bnn/an/a
us flag iconMRUSMerus NV$3.94bnn/an/a
us flag iconRYZBRayzebio$3.81bnn/an/a
us flag iconCBAYCymaBay Therapeutics$3.73bnn/an/a
us flag iconACADAcadia Pharmaceuticals$3.70bn37.54n/a
us flag iconACLXArcellx$3.60bnn/an/a
us flag iconPTGXProtagonist Therapeutics$3.45bn73.41n/a
us flag iconSRRKScholar Rock Holding$3.40bnn/an/a
us flag iconMLTXMoonLake Immunotherapeutics$3.05bnn/an/a
us flag iconMTSRMetsera$3.00bnn/an/a
us flag iconVKTXViking Therapeutics$2.98bnn/an/a
us flag iconKDNYChinook Therapeutics$2.90bnn/an/a
us flag iconKYMRKymera Therapeutics$2.87bnn/an/a
us flag iconMORFMorphic Holding$2.86bnn/an/a
us flag iconCRNXCrinetics Pharmaceuticals$2.81bnn/an/a
us flag iconALVOAlvotech SA$2.77bn18.69n/a
us flag iconIMVTImmunovant$2.75bnn/an/a
us flag iconAPGEApogee Therapeutics$2.58bnn/an/a
us flag iconXENEXenon Pharmaceuticals$2.49bnn/an/a